FDA Provides Draft Guidance on Risk Management Plans for Preventing Drug Shortages
- May 20, 2022
The Food and Drug Administration issued May 19 draft guidance to help drug manufacturers develop, maintain, and implement risk management plans (RMPs) to help avoid shortages of drugs and biological products.
ARTICLE TAGS
You must be logged in to access this content.